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Abstract
Background: High-throughput screening using RNAi is a powerful gene discovery method but is often
complicated by false positive and false negative results. Whereas false positive results associated with RNAi
reagents has been a matter of extensive study, the issue of false negatives has received less attention.
Results: We performed a meta-analysis of several genome-wide, cell-based Drosophila RNAi screens, together with
a more focused RNAi screen, and conclude that the rate of false negative results is at least 8%. Further, we
demonstrate how knowledge of the cell transcriptome can be used to resolve ambiguous results and how the
number of false negative results can be reduced by using multiple, independently-tested RNAi reagents per gene.
Conclusions: RNAi reagents that target the same gene do not always yield consistent results due to false positives
and weak or ineffective reagents. False positive results can be partially minimized by filtering with transcriptome
data. RNAi libraries with multiple reagents per gene also reduce false positive and false negative outcomes when
inconsistent results are disambiguated carefully.
Background
The success of RNAi high throughput screening (HTS)
relies on low experimental rates of false negative and
false positive results, which in turn depend on the effi-
cacy and specificity of the RNAi reagents, respectively
(reviewed in [1,2]). False positive results can arise from
at least the following causes: experimental noise inher-
ent to large-scale studies, bias associated with a particu-
lar screen assay, incorrect gene models, and arguably
most importantly, reagent-specific off-target effects
(OTEs) (reviewed in [3]). Similarly, false negative results
can arise as the result of experimental noise [4,5],
aspects of screen assay design, and incorrect gene mod-
els, protein stability, gene redundancy, but most impor-
tantly, the rate of false negative results depends on the
efficacy of the RNAi reagents used in the screen.
The issue of false positive results associated with
RNAi reagents has been a matter of extensive study in
recent years for screens in both Drosophila and mam-
malian cells [6-11]. In Drosophila cell-based RNAi
screens, the focus of this study, cultured cells are treated
with long double-stranded RNAs (dsRNAs) as the
reagent for knockdown. Sequence-associated false posi-
tive results have been observed and characterized to a
significant extent [10,11]; however, the full cause of the
phenomenon remains to be elucidated. There are a
number of ways to identify false positives in a screen,
for example using ‘gold standard’ rescue methods
[12,13]. By contrast, the identification of false negatives
is not as straightforward, as identification of a false
negative result requires previous knowledge that a gene
is involved in the process under analysis. Thus, rates of
false negative results have been estimated for screens
that investigated well-characterized pathways. For exam-
ple, in a screen for Hedgehog (Hh) signaling factors,
only nine of fourteen known components of the path-
way were identified [14] and only seven of these passed
additional validation [15], suggesting a rate of false
negative results of nearly 48%. Similarly, in a screen for
Wingless (Wg)/Wnt signaling, only 16 of 21 canonical
components expressed in the cell line used were identi-
fied in the screen [16]. Interestingly, when the “hits”
(positive results) from the Wg screen were re-tested
using three independent dsRNAs, 70 of 204 genes tested
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with only two out of three, suggesting a false negative
rate of 16% [15]. Altogether, these analyses have sug-
gested that false negative rates may be in the order of
16% to 50% in RNAi HTS.
One caveat to the studies that to date have looked at
false negative rates in RNAi HTS is that the sample
sizes were small. In order to get a more global view of
false negative rates in Drosophila cell-based RNAi HTS,
we decided to perform a number of analyses on a larger
set of screens. The data sets we analyzed were from
RNAi screens performed at the Drosophila RNAi
Screening Center (DRSC) [17] where a standardized
screening platform enables both local and visiting scien-
tists to perform high-throughput screens with dsRNAs
in Drosophila cell tissue culture. Each of the screens we
analyzed used essentially the same dsRNA library
(DRSC “2.0”) and a standard cell line (S2, S2R+ or
Kc167), such that variability due to equipment and
reagents should be minimal. We also used data from
DRSC screens in conjunction with an analysis of the
transcriptome of cell lines [18] to estimate an overall
f a l s ep o s i t i v er a t ea m o n gl o n gd s R N A so fr o u g h l y1 %
and a false negative rate due to ineffective or weak
dsRNAs of at least 8%. Furthermore, we find that the
presence of multiple RNAi reagents per gene in a
screening library can be a statistically powerful means of
reducing false positive and negative results, although
careful consideration must be made regarding the dis-
ambiguation of inconsistent results obtained with multi-
ple reagents directed against the same target gene.
Results
Estimation of false negative rates using data from RNAi
reagents directed against ribosome and proteasome
components
The proteasome and ribosome are two well-characterized
complexes in the cell that perform the essential functions
of protein degradation and protein assembly, respectively.
Because of the broad functionality of the ribosome and
proteasome in basic cell metabolism, we reasoned that
dsRNAs targeting components of these complexes might
affect the output of a wide range of RNAi screens.
Indeed, we find that dsRNAs targeting ribosomal or pro-
teasome components frequently score as “hits” (positive
results) in many screens thus making them particularly
useful for analysis of false negative results. We used the
Gene Ontology (GO) annotations at FlyBase [19] to
select 185 genes with the GO:0005840: Ribosome annota-
tion, and 58 genes with GO:0000502: Proteasome Com-
plex (Additional file 1). Of the 185 ribosomal genes, a
sub-set of 94 genes are also annotated with GO:0022626:
Cytosolic Ribosome.
We next selected 16 screens performed at the DRSC
(see Materials and Methods) using version 2 of the DRSC
genome-wide library, which was designed to minimize
OTEs [15], and determined the scoring pattern of the
ribosome and proteasome set for these screens. Two pro-
minent clusters with strongly scoring dsRNAs clearly
emerge (Figure 1A; Additional file 1): a “cytosolic ribo-
some cluster” that consists of 79 genes enriched for
GO:0022626: Cytosolic Ribosome and a “proteasome
complex cluster” that consists of 36 genes enriched for
GO:0000502: Proteasome Complex. For each cluster, a
“screen signature” was calculated by determining for each
screen the mean Z-score of the dsRNAs in the cluster.
The screen signatures for the proteasome complex and
cytosolic ribosome clusters are shown in Figures 1B and
1C, respectively. Outside of these two clusters, the major-
ity of dsRNAs are those that target components of mito-
chondrial ribosome. Unlike the cytosolic ribosome
components, these do not appear to show strong pheno-
types across multiple RNAi screens.
Some cytosolic ribosome and proteasome complex
genes are absent from their respective clusters and lack
functionally typical screen signatures. Overall, 22 of 94
cytosolic ribosome genes and 29 of 58 proteasome com-
plex genes failed to yield the appropriate screen signa-
ture (Additional file 2). Possibilities for these failures
include functional mis-annotation of genes or protection
from loss-of-function phenotypes due to gene redun-
dancy. Additionally, some of the non-clustering cytosolic
ribosome and proteasome complex genes may represent
false negatives due to insufficient knockdown.
When there is only a single dsRNA targeting the gene
that did not result in the predicted screen signature, it is
not possible to distinguish among potential causes of
negative results. Fortunately, however, DRSC library ver-
sion 2 has two or more dsRNAs per gene for many genes
represented in the library. In principle, because dsRNAs
that target the same gene should yield similar screen sig-
natures, we can ask if this is the case when two such
dsRNAs against the same gene exist in the collection.
Within the proteasome complex and cytosolic ribosome
clusters, there are 51 genes represented by two dsRNAs in
the dsRNA library for a total of 103 dsRNAs (in one case
three dsRNAs targeted a single gene). Of these 51 genes,
42 have dsRNAs that exhibit the appropriate screen signa-
tures. In 9 cases however, only one dsRNA appears either
in the cytosolic ribosome cluster (Figure 2A) or the pro-
teasome complex cluster (Figure 2B). In 8 of these 9 cases,
the gene target is well known and functionally consistent
with the cluster in which one of its dsRNAs appears
(DRSC03201, which targets Pomp, clusters in the periph-
ery of the cytosolic ribosome cluster and is most likely a
false positive). Because for 8 genes, one dsRNA gave the
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Page 2 of 11Figure 1 Identification of Proteosome and Ribosome signatures in RNAi screens. All dsRNAs included in the dendrogram target 243
proteasome and ribosome-related genes. Red indicates an increase in signal and green indicates a decrease in signal. (A) Results of clustering
RNAi phenotypes in 16 screens of dsRNAs targeting ribosome and proteasome genes as defined by GO terms (see Materials and Methods). The
proteasome complex and cytosolic ribosome clusters are highlighted in blue and green, respectively. The simple majority of dsRNAs outside
these two clusters target mitochondrial ribosome components. (B) Consensus screen signature of the proteasome complex cluster. Each small
square represents the mean Z-score of the dsRNAs in the proteasome complex cluster across a single screen. (C) Consensus screen signature of
the cytosolic ribosome cluster. The 16 screens are as follows from the left to the right: 1. Hormone receptor screen, plate-reader (unpublished),
2. Oncogenesis screen, plate-reader (unpublished), 3. Protein degradation screen, plate-reader (unpublished), 4. RNA processing screen, plate-
reader (unpublished), 5. Mitochondrial calcium ion and proton antiporter screen, plate-reader [37], 6. Toxicity screen, plate-reader (unpublished),
7. Dengue virus host factors screen, image-based [38], 8. Ion homeostasis screen, plate-reader (unpublished). 9. Pathogen infection screen,
image-based (unpublished), 10. Signaling pathway screen, plate-reader (unpublished), 11. Ion transport screen, plate-reader (unpublished),
12. Cytoskeleton regulation screen, image-based (unpublished), 13. Chromatin regulation screen, image-based (unpublished), 14. Francisella
tularensis infection screen, plate-reader [39], 15. mRNA processing screen, plate-reader (unpublished), 16. Protein secretion screen, plate-reader
(unpublished).
Booker et al. BMC Genomics 2011, 12:50
http://www.biomedcentral.com/1471-2164/12/50
Page 3 of 11expected screen signature but the other did not, the non-
signature dsRNAs are likely false negatives. Thus, we con-
clude that 8 out of 103 dsRNAs failed to cluster as
expected, yielding to a false negative rate due to ineffective
RNAi reagents at 8%. Because this estimate is derived
from a meta-analysis of multiple screens, the most likely
explanation for these false negative is weak or ineffective
dsRNAs rather than statistical noise from an individual
screen.
Note that the 8% rate is likely under-estimated since
we did not take into account the false negative rate pre-
sent in the initial screen. Our reasoning for not includ-
ing them is that we do not know whether the genes that
did not score initially should have scored in the assays.
Regardless, if we do include those, the false negative
rate is higher and reaches 34% [(22+29)/(94+58)]. Test
of additional dsRNAs will be necessary to address
whether these are genuine false negatives or not.
Use of focused RNAi libraries with multiple reagents
per gene as a strategy to minimize the rate of false
negative results
The past and current DRSC genome-wide Drosophila
libraries included redundant dsRNAs for only a subset
of the genome, thus limiting our ability to fully assess
rates of false negative results using full-genome screen
datasets. To address this issue, we generated sub-
libraries containing multiple RNAi reagents (2 to 4) for
several specific gene families (see Materials and Meth-
ods), such that analysis of results from a sub-library
should supplement the results reported from genome-
wide screens. Similar to the cluster analysis presented
above, the sub-library sets allow for comparison of the
behavior of multiple reagents per gene. Additionally, the
layout of the sub-library assay plates was designed with
an outer perimeter of wells that lack dsRNAs to reduce
the possible influence edge effects that occur in many
screens [20]. Currently, four sub-libraries have been
generated: a kinases and phosphatases sub-library (K/P),
a transcription factor and DNA binding sub-library
(TRXN), a transmembrane domain-containing protein
sub-library (TM), and a library which covers genes
involved in ubiquitination and related processes (UBIQ)
(Table 1). Like version 2 of the DRSC genome-wide
library, these sub-libraries were designed with SnapDra-
gon [21] to avoid sequences known to cause OTEs (see
Materials and Methods).
K/P screen for JAK/STAT signaling pathway components:
a case study in identification of false discovery rates
To demonstrate the utility of focused libraries with mul-
tiple amplicons per gene, we screened the K/P set for
factors involved in the JAK/STAT pathway. S2R+ cells
were transfected with dsRNA and both 10xSTAT-firefly
Figure 2 Estimation of the rate of false negatives for the Ribosome (A) and Proteasome (B) set. Red indicates an increase in signal and
green indicates a decrease in signal. (A) The cytosolic ribosome screen signature is compared to the screen signatures in those cases where one
dsRNA is part of the cytosolic ribosome cluster and the other is not. dsRNAs with a screen signature similar to the consensus cytosolic ribosome
signature are italicized. Pearson’s correlation is shown between dsRNAs that target the same gene as well as the correlation between each
dsRNA and the consensus signature. (B) Similar comparison for the proteasome complex screen signature.
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Page 4 of 11luciferase and actin-renilla luciferase constructs as pre-
viously described ([22]; Materials and Methods). The
pathway was stimulated three days later by the addition
of S2NP cells transfected with a plasmid expressing the
Unpaired ligand [22], and JAK/STAT pathway activity
quantified by measuring firefly luciferase activity. Renilla
luciferase activity was used for normalization. The
redundant coverage of genes in the K/P library provides
an opportunity to compare the behavior of dsRNAs that
target the same gene. The K/P set contains two canoni-
cal positive regulators of JAK/STAT signaling with three
dsRNAs each: domeless (dome), which was initially
annotated as a phosphatase [23], and the kinase hops-
cotch (hop) (reviewed in [24]). All dsRNAs targeting
dome and hop were strong hits in the screen, with
Z-scores less than -4. The K/P set also contains one
canonical negative regulator of JAK/STAT signaling,
Ptp61F. The three dsRNAs for this gene did not score,
most likely because over-stimulation with the act-upd
construct makes it difficult to detect negative regulators
of JAK/STAT signaling in S2R+ cells [25].
For further analysis, we selected those dsRNAs with
Z-scores with an absolute value of 2 or greater across
both replicates, which in this case included dsRNAs tar-
geting 24 genes (Figure 3, Table 2). We then compared
these to the Z-scores of the other dsRNAs in the K/P
s e tt h a tt a r g e tt h es a m eg e n ea n dt r a n s c r i p t s .I ns o m e
cases, the scores obtained with all dsRNAs directed
against a particular gene were consistent, whereas in
other cases, some dsRNAs directed against a single gene
were phenotypically inconsistent. We categorized the
results of dsRNAs into three categories: In category 1,
all dsRNAs directed against a given gene were hits. In
category 2, at least 2 dsRNAs were hits but there was at
least one which did not score significantly. In category
3, only 1 dsRNA directed against a gene yielded a signif-
icant result. Out of 24 genes, 5 had positive results for
all dsRNAs (category 1), 4 were in category 2, and 15
were in category 3 (Figure 3, Table 2).
Using transcriptome analysis to preferentially filter
false positives
In those cases where we observed discrepancies (cate-
gories 2 and 3), we determined whether the targeted
gene was expressed in S2R+ cells using expression data-
sets [18]. In principle, this information could be extre-
mely useful for data curation, as dsRNAs that score but
for which there is no evidence that the gene is expressed
in the cell line tested are likely false positives. Impor-
tantly, transcriptome information may not only help to
resolve many ambiguous false positive cases but also
help identify false negatives, as the inconsistent dsRNAs
that have been ruled out to be due to false positives
should be enriched for false negatives.
Analysis of the transcriptional activity in S2R+ cul-
tured cells provides evidence for expression of 7,069
genes (see Materials and Methods). Of these, 6,223 (or
45%) of annotated protein-coding genes are expressed at
elevated levels (FPKM >= 5). Of the genes in the K/P
sub-library, 70% are expressed in S2R+ cells. Impor-
tantly, we found evidence that all of the core compo-
nents of the JAK/STAT pathway required for signal
transduction are expressed in S2R+ cells (Figure 4).
Interestingly, the Upd ligands are either not expressed
or expressed at low levels, suggesting that the JAK/
STAT pathway is either not active or active at low levels
in cultured cell lines, which is consistent with the fact
that stimulation with act-upd was necessary to activate
the pathway for our RNAi screen (see Materials and
Methods).
Of the 24 genes found in the K/P screen, 16 are
expressed in S2R+ cells (Figure 3, Table 2). All category
Table 1 List of RNAi sub-libraries
Library Gene Set Number of
Genes
dsRNAs per
Gene
DRSC K/P Kinases &
Phosphatases
563 2-4
DRSC TRXN Transcription Factors 993 2
NYU-DRSC
UBIQ
Ubiquitin-Related
Genes
439 2-3
NYU-DRSC
TM
Transmembrane
Proteins
1729 2
The gene lists are available [40]. The UBIQ and TM sub-libraries were
developed in conjunction with the RNAi Core Facility at New York University
(NYU) [41].
Figure 3 Results of the JAK/STAT signaling screen. The number
of genes binned by the number of dsRNAs that scored out of the
number of dsRNAs screened is shown. These are color-coded
further: Blue for category 1 in which all dsRNAs scored, Green for
category 2 in which at least two dsRNAs scored and maroon for
category 3 in which only one dsRNA scored. The beige column to
the right indicates the number of genes in each binned category
that are expressed in S2R+ cells.
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sented by multiple scoring dsRNAs, suggesting that the
f e wd s R N A st h a td i dn o ts c o r ea r em o s tl i k e l yf a l s e
negatives. Categories 1 and 2 represent results from 37
dsRNAs of which 5 did not score. Therefore, we esti-
mate a false negative rate of ~13%, which is roughly
consistent with the ~8% estimate from the ribosome
and proteosome cluster analysis described above. All 8
of the unexpressed genes are limited to the 15 category
3 genes for which only a single dsRNA scored (Figure 3,
Table 2). Therefore, these 8 genes should be considered
false positive results and should be viewed as low prior-
ity for selection for additional validation.
Since only 7 of the 15 category 3 genes are expressed
(47%), category 3 genes show no enrichment for
expressed genes. This suggests that few, if any of cate-
gory 3 genes, for which a single dsRNA scored, repre-
sent true positives. Thus, assuming that all 15 category
3 dsRNAs are false positives, the overall rate of false
positives for this K/P screen is 1% since we screened
1,545 dsRNAs in total. It is important to note that
although 1% appears to be an acceptable low rate, when
the same false positive rate is shown as a percentage of
the genes identified as positives in the screen, the figure
is 62% (15 out of 24; Figure 3, Table 2), thus, underscor-
ing the need for further validation of primary hit lists.
Knowledge of the transcriptome of the cell line used in
our K/P JAK/STAT screen allowed us to estimate the
false positive rate, as few unexpressed genes are expected
to be legitimate hits. Likewise, in any screen, failure to
uncover some expected hits can sometimes be explained
by the finding that those genes are simply not expressed
in the specific cell line tested. In turn, this allows an esti-
mate of false negatives in conjunction with multiple
reagents per gene. To assist such analyses, we have ana-
lyzed gene expression based on deep-sequencing data
obtained by the modENCODE consortium [18] for five
Drosophila cell lines commonly used in RNAi HTS
Table 2 Hits organized by genes in the K/P JAK/STAT screen
Gene Number of dsRNAs Number of scoring dsRNAs Number of non-scoring dsRNAs Category Expressed in S2R+ Cells
Abl 4 4 0 1 Yes
CycA 3 3 0 1 Yes
dome 3 3 0 1 Yes
hop 3 3 0 1 Yes
mts 2 2 0 1 Yes
CycE 3 2 1 2 Yes
Pp4-19C 4 2 2 2 Yes
CG17090 3 2 1 2 Yes
puc 3 2 1 2 Yes
CG34318 | CG8179 4 1 3 3 No
CanA1 3 1 2 3 No
CG4839 3 1 2 3 No
CG7597 3 1 2 3 Yes
CG9389 3 1 2 3 No
mtm 3 1 2 3 Yes
Pi3K21B 3 1 2 3 Yes
smi35A 3 1 2 3 Yes
Src42A 3 1 2 3 Yes
CG8509 2 1 1 3 No
gskt 2 1 1 3 No
htl 2 1 1 3 No
Myt1 2 1 1 3 Yes
Pp1-Y2 2 1 1 3 No
S6k 2 1 1 3 Yes
Genes were included on this list if at least one dsRNA yielded a Z-score of +/- 2 or better across both replicates. The number of dsRNAs in the K/P set is indicated as
well as the number of those dsRNAs that were scored in the screen with a Z-score with an absolute value of 1.5 or better. Genes were binned into 3 categories:
Category 1 contains genes where 4 out of 4 or 3 out of 3 or 2 out of 2 dsRNAs scored. Category 2 contains genes where 2 out of 3 or 2 out of 4 or 3 out of 4 dsRNAs
scored. Category 3 contains genes where only 1 dsRNA scored. A gene was defined to be expressed in S2R+ if the FPKM value was greater than 1.
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([26], see Materials and Methods). Each of the cell lines
expresses about 53% of protein-coding genes in the gen-
ome but the specific sub-set of genes that are expressed
differs somewhat among the cell lines. We identified
6,230 genes expressed in all five cell lines, representing
46% of annotated protein-coding genes in release 5.22 of
the Drosophila genome. False positives and false nega-
tives can also potentially be filtered using tools based on
protein interaction networks such as RNAiCut [27] and
NePhe [28].
Discussion
This study has focused on false negative rates among
long dsRNAs used in Drosophila RNAi screens in cul-
tured cells. Although the exact rates will vary depending
on the reagent library, assay design, and the level of sta-
tistical noise, our analysis provides a detailed example of
the issues that need to be considered carefully in the
data analysis of an RNAi screen. Importantly, other
RNAi reagents, such as siRNAs, shRNAs, and siRNA
pools used in mammalian RNAi screens, have their own
false positive and false negative rates and these are
not necessarily the same as what we observed with Dro-
sophila long dsRNAs. Regardless of the reagent used,
however, any false negative rate significantly above zero
will cause genes to be missed in an RNAi screen. Like-
wise, as shown in the K/P screen, even a very low false
positive rate among the set of reagents can yield a very
high proportion of false positives when expressed as a
percentage of the hits obtained in an individual screen.
Finally, our study illustrates how transcriptome data
from the cell lines can be included as part of the data
analysis to eliminate false positives.
The existence of false negatives due to ineffective
RNAi reagents necessitates strategies for reducing their
effects on the outcomes of RNAi screens. One obvious
approach to minimize false negatives in screens is to use
multiple, independently screened reagents per gene, as
done in some recent RNAi screens [29,30]. In principle,
use of multiple reagents per gene should reduce the
number of false negatives, as a single ineffective RNAi
reagent would be compensated by those that are effec-
tive. An obvious caveat to this, however, is that simply
by including more reagents, the number of false positive
results will also increase.
To explore how multiple RNAi reagents per gene
could affect the outcome of a screen and to determine
the best strategy for disambiguating results when differ-
ent reagents yield inconsistent results, we devised a sim-
ple model of one, two, and three reagents per gene
(Table 3). Furthermore, we examined three simple gen-
eralized disambiguation approaches and modeled how
these approaches would affect the outcome of a screen.
These disambiguation approaches are as follows: a leni-
ent approach wherein a gene is considered a hit if any
RNAi reagent directed against that gene scores above
some threshold (Table 3, Rule A); a stringent approach
that requires all reagents directed against the same gene
to score (Table 3, Rule B); and an intermediate approach
that requires more than half of the reagents directed
a g a i n s tt h es a m eg e n et os c o r e( T a b l e3 ,R u l eC ) .F o r
the purpose of this model, an RNAi “mini-pool” of
reagents, such as is sometimes used for mammalian
siRNA knockdown, or combinatorial knockdown with
multiple dsRNAs, counts as a single RNAi reagent
unless the individual components are tested separately.
To illustrate the model, we chose as an example three
hypothetical Drosophila genome-wide dsRNA libraries
with false negative and false positive rates of 10% and
1% respectively (Figure 6). The model shows that the
strategy used to disambiguate results from multiple
reagents is critical when interpreting results from a
library with more than one independently tested reagent
per gene. In a hypothetical library with three reagents
per gene, a lenient interpretation (requiring one or more
of three reagents to score) results in few false negatives
but an extremely high number of false positives in the
outcome of a screen (Table 3 and Figure 6, Rule A). In
this scenario, the presence of multiple reagents per gene
virtually eliminates false negatives but at the cost of a
high number of false positives as illustrated by our K/P
JAK/STAT screen which would have a 62% final false
positive rate (in terms of the percentage of hits) if
Figure 4 Transformed expression levels of core components of
JAK-STAT signaling pathway. Genes expressed at low and high
levels are displayed in gradations of black and red, correspondingly.
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Cl.8 Cl.8
Kc167 Kc167 S2-DRSC S2-DRSC
S2R+ S2R+
7109 7109
7146 7146
7398 7398 7302 7302
7069 7069
6855
6711
6572 6673
6792
51.43% 51.43%
51.14% 51.14%
52.82% 52.82% 53.52% 53.52%
51.69% 51.69%
6320 6320
6455 6455
6432 6432
6549 6549
6633 6633 6553 6553
Figure 5 Number of genes expressed in different cell lines at FPKM levels greater than one. The cell lines included in the analysis are
Kc167, Clone8, S2, BG3, and S2R+. 6,320 genes are expressed in all five cell lines.
Table 3 Model of RNAi reagent disambiguation methods under one, two or three reagents per gene
1 RNAi Reagent/Gene 2 RNAi Reagents/Gene 3 RNAi Reagents/Gene
“Lenient” Rule A: Number of False Negatives RFN × H RH FN
2 × RH FN
3 ×
“Lenient” Rule A: Number of False Positives RFP × N RR N FP FP ×− () × 2
2 RRR N FP FP FP ×− ×+ () × 33
23
“Stringent” Rule B: Number of False Negatives RFN × H RR H FN FN ×− () × 2
2 RRR H FN FN FN ×− ×+ () × 33
23
“Stringent” Rule B: Number of False Positives RFP × N RN FP
2 × RN FP
3 ×
“Balanced” Rule C: Number of False Negatives RFN × H RR H FN FN ×− () × 2
2 RR H FN FN
23 32 ×− × () ×
“Balanced” Rule C: Number of False Positives RFP × N RN FP
2 × RR N FP FP
23 32 ×− × () ×
N = The number of genes in the screening library, H = The number of genes a screen should uncover under ideal conditions, RFN = Fraction of reagents of H
that fail. RFP = Fraction of reagents of N that are false positives. Rule “A": Only one reagent targeting a gene need to be a “hit” for the gene to be called a “hit”.
Rule “B": All reagents targeting a gene need to be a “hit”.R u l e“C": More than half of reagents must score as a “hit”.
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ing all three reagents to score) results in few false posi-
tives but a high number of false negatives (Tables 3 and
Figure 6, Rule B).
A third possible strategy for libraries with three
reagents per gene (Tables 3 and Figure 6, Rule C)
requires two out of three RNAi reagents to score. This
disambiguation method achieved a balance of false nega-
tives and false positives, resulting in low numbers of
each relative to what would be achieved by screening a
single dsRNA per gene. Thus, adding additional reagents
per gene can greatly reduce false negative rates in
screens but can also greatly increase the number of false
positives in the absence of careful disambiguation.
For Drosophila cell-based RNAi screens, a library with
three dsRNAs per gene, wherein discrepancies are dis-
ambiguated by requiring two of three dsRNAs to score,
achieves a good balance between false negatives and
false positives. For RNAi reagents with significantly dif-
ferent reagent-level false positive and false negatives
rates, a different number of reagents with a different dis-
ambiguation strategy may be more appropriate. Indeed,
several groups have proposed using four or more siR-
NAs per gene in mammalian siRNA screens [4,31].
Moreover, our model and disambiguation strategy is
based on a simple binary interpretation of hits, but
other more quantitative approaches have been proposed
that do not require a screener to designate individual
reagents as hits or non-hits. A recently described
approach for disambiguating image-based RNAi screens,
quantitative multiparametric image analysis (QMPIA),
can be applied to complex screens with a very large
number of read-outs [29]. A more broadly applicable
quantitative disambiguation approach, the redundant
siRNA activity (RSA) method [31], requires only one
read-out per RNAi experiment. Regardless of the disam-
biguation approach used, screeners must carefully inter-
pret results obtained with multiple reagents per gene in
order to reduce false negative results without increasing
the number of false positive results to an unacceptably
high level.
Conclusions
RNAi reagents that target the same gene do not always
yield consistent results. Some of these inconsistencies
can be explained by false positives and off-target effects,
but some RNAi reagents are weak or ineffective and
cause false negative results. False positive results and
off-target effects can be partially filtered by using cell-
line transcriptome expression data, and we have pre-
sented a web-tool to enable Drosophila cell-based RNAi
screeners to filter screen results. RNAi libraries with
multiple reagents per gene enable a reduction in false
positive and false negative outcomes so long as care is
taken when disambiguating inconsistent results to pre-
vent an unintentional increase in false positive or false
negative results.
Methods
Construction of the RNAi sub-libraries
RNAi “sub-libraries” were constructed by selecting genes
based on known and predicted function as determined
by FlyBase [19] supplemented with curation of the lists
by experts. For each gene, two to four dsRNAs were
selected from existing libraries or designed de novo
using SnapDragon [21]. SnapDragon is a dsRNA design
tool that selects gene regions common to splice forms
and avoids sequences known to cause OTE [10,11].
Figure 6 Number of False Negatives and False Positives under hypothetical screening scenarios. We assume a false positive rate of 1%
and a false negative rate of 10%, a scenario of 100 “true hits” in the library, and a library targeting 13,735 protein-encoding genes. (A) The
predicted number of false negatives with 1, 2, or 3 dsRNAs per gene under 3 different rules for interpreting ambiguous cases. (B) The predicted
number of false positives with 1, 2, or 3 dsRNAs per gene under 3 different rules for interpreting ambiguous cases.
Booker et al. BMC Genomics 2011, 12:50
http://www.biomedcentral.com/1471-2164/12/50
Page 9 of 11RNAi reagents were constructed based on previously
described protocols [32], dsRNAs were normalized to a
dilution of 50 ng/ul, and 5 ul of this was aliquoted into
each well of 384-well plates.
JAK/STAT screen
A kinases and phosphatases sub-library screen was per-
formed as described previously with minor modifications
[22]. Briefly, S2R+ cells were transfected with dsRNA and
two reporter constructs (10xSTAT-fire fly luciferase and
actin-renilla luciferase). Three days later, the JAK/STAT
pathway was stimulated via the addition of S2NP cells
transfected with a plasmid expressing the JAK/STAT
pathway ligand Unpaired (actin-Unpaired/act-upd) [22].
JAK/STAT signaling activity was quantified by measuring
firefly luciferase activity, as the expression of firefly luci-
ferase is under the control of 10 repeats of a STAT bind-
ing sequence. We used ubiquitously expressed Renilla
luciferase activity to normalize for transfection efficiency
and cell viability. The normalized luciferase values were
used to calculate Z-scores. A Z-score for a well is calcu-
lated using the formula: (x - μ)/s w h e r exi st h ev a l u eo f
the well, μ is the mean value across all wells of the plate,
and s is the standard deviation of the well values of the
plate.
Cluster analysis
RNAi screens performed using the DRSC “2.0” genome-
wide library (i.e. the most updated genome-wide library)
were selected for analysis. Raw data from these screens
were normalized using a standard plate-based Z-score
analysis. The screens included are diverse in terms of
assay read-outs and the subject under investigation; they
include image-based screen assays, fluorimeter and
luminometer (i.e. plate-reader) assays and investigated
topics such as cell signaling pathways, pathogen infec-
tion, ion transport, cell viability, cellular and sub-cellular
morphology, and RNA processing.
The 243 genes that target ribosome and proteasome
components were selected based on Gene Ontology
annotations in FlyBase [19]. A complete list of the
dsRNAs analyzed in the study, which correspond to this
set of 243 genes, can be found in Supplementary Table
S1. The screen results obtained with dsRNAs targeting
these genes were clustered based on their Z-scores
across the screens using Cluster 3.0 [33] using Pearson’s
correlation and average linkage hierarchical clustering.
Transcriptome analysis
To characterize gene expression levels, we used deep
sequencing data obtained by the modENCODE consor-
tium and available online [34] for the BG3, Cl.8, Kc167,
S2-DRSC and S2R+ cultured cell lines. The first four
cell lines were sequenced by modENCODE using 37 nt
paired-end reads on the Illumina GAIIx platform (GEO
Accession GSE15596) [18]. In addition, we analyzed
s a m p l e so b t a i n e df r o mt h eS 2 R +c e l ll i n et h a tw e r e
sequenced with the same platform in a strand-specific
manner using a combination of single and paired-end
reads of different lengths (76 nt and 108 nt, respectively.
The reads were aligned the genome (FlyBase release
5.22) using TopHat [35] with up to two mismatches
allowed and a mapping limit of 40 potential locations.
Cufflinks [36] was used to estimate the level of expres-
sion of the annotated protein-coding genes. An FPKM
(Fragments per Kilobase of gene/transcript model per
million fragments mapped) value of 1 was set as a
threshold for expressed genes. The expression of any
gene in each cell line can be searched using the DRSC
Cell Lines Expression Levels web-tool [26].
Additional material
Additional data file 1: Supplemental Table S1: dsRNA membership of
the proteasome complex cluster and the cytosolic ribosome. Each gene
is categorized as Proteasome, Ribosome, or Mitochondrial Ribosome. In
bold are the 45 and 111 dsRNAs that belong to the proteasome and
cytosolic ribosome clusters highlighted in Figure 2B and Figure 2A,
respectively.
Additional data file 2: Supplemental Table S2: dsRNAs targeting the
cytosolic ribosome and proteasome complex components that failed to
appear in their respective clusters.
List of abbreviations
RNAi: RNA interference; HTS: High throughput screening; OTE: Off-target
effect; dsRNA: double-stranded RNA; DRSC: Drosophila RNAi Screening
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